Company / EPS (Diluted)
Celularity Inc EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.64
FY2025
5-year range
-$11.31 / $0.95
FY2021-FY2025
Trend
+76.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.95 to $-2.64 over the past 2 years.
Based on SEC 10-K filings.
-2.64 in FY2025.
Declined from $0.95 to $-2.64 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 76.0% year-over-year.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.64 | +76.0% |
| FY2024 | -$11.02 | -1260.0% |
| FY2023 | $0.95 | +163.8% |
| FY2022 | -$1.49 | +86.8% |
| FY2021 | -$11.31 | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026